טוען...
Astragaloside IV alleviates the symptoms of experimental ulcerative colitis in vitro and in vivo
Ulcerative colitis (UC) is a chronic and relapsing inflammatory intestinal disease. Although the morbidity of UC has increased notably in recent years, effective therapeutic treatment remains unsatisfactory. Astragaloside IV (ASI), a monomeric compound isolated from the traditional Chinese medicine...
שמור ב:
| הוצא לאור ב: | Exp Ther Med |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
D.A. Spandidos
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6755457/ https://ncbi.nlm.nih.gov/pubmed/31572532 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2019.7907 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|